<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>27(6)</volume><submitter>Lan YH</submitter><pubmed_abstract>Euphormin-A (1) and euphormin-B (2), two new pyranocoumarin derivatives, and forty known compounds (3-42) were isolated from Euphorbia formosana Hayata (Euphorbiaceae). The chemical structures of all compounds were established based on spectroscopic analyses. Several isolates were evaluated for their anti-inflammatory activity. Compounds 1, 2, 10, 18, 25, and 33 significantly inhibited against superoxide anion generation and elastase release by human neutrophils in response to formyl-L-methionyl-L-leucyl-L-phenylalanine/cytochalasin B (fMLP/CB). Furthermore, compounds 25 and 33 displayed the most potent effects with IC50 values of 0.68 ± 0.18 and 1.39 ± 0.12 µM, respectively, against superoxide anion generation when compared with the positive control (2.01 ± 0.06 µM).</pubmed_abstract><journal>Molecules (Basel, Switzerland)</journal><pagination>1885</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8954059</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Euphormins A and B, New Pyranocoumarin Derivatives from Euphorbia formosana Hayata, and Their Anti-Inflammatory Activity.</pubmed_title><pmcid>PMC8954059</pmcid><pubmed_authors>Hwang TL</pubmed_authors><pubmed_authors>Leu YL</pubmed_authors><pubmed_authors>Lu HH</pubmed_authors><pubmed_authors>Chen IH</pubmed_authors><pubmed_authors>Guo TJ</pubmed_authors><pubmed_authors>Lan YH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Euphormins A and B, New Pyranocoumarin Derivatives from Euphorbia formosana Hayata, and Their Anti-Inflammatory Activity.</name><description>Euphormin-A (1) and euphormin-B (2), two new pyranocoumarin derivatives, and forty known compounds (3-42) were isolated from Euphorbia formosana Hayata (Euphorbiaceae). The chemical structures of all compounds were established based on spectroscopic analyses. Several isolates were evaluated for their anti-inflammatory activity. Compounds 1, 2, 10, 18, 25, and 33 significantly inhibited against superoxide anion generation and elastase release by human neutrophils in response to formyl-L-methionyl-L-leucyl-L-phenylalanine/cytochalasin B (fMLP/CB). Furthermore, compounds 25 and 33 displayed the most potent effects with IC50 values of 0.68 ± 0.18 and 1.39 ± 0.12 µM, respectively, against superoxide anion generation when compared with the positive control (2.01 ± 0.06 µM).</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Mar</publication><modification>2025-04-22T19:18:28.523Z</modification><creation>2025-04-06T02:39:59.169Z</creation></dates><accession>S-EPMC8954059</accession><cross_references><pubmed>35335252</pubmed><doi>10.3390/molecules27061885</doi></cross_references></HashMap>